XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Stockholders' (Deficit) - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total
Balance (in shares) at Dec. 31, 2023 75,708,889        
Balance at the beginning of the period at Dec. 31, 2023 $ 75 $ 2,466,233 $ (1,285) $ (3,283,578) $ (818,555)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 181,444        
Exercise of options   4,747     4,747
Restricted stock vesting and issuance, net (in shares) 902,645        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 107,145        
Issuance of common stock in connection with an employee stock purchase plan   1,973     1,973
Share-based compensation expense   37,621     37,621
Net (loss) income       (190,755) (190,755)
Comprehensive income (loss)     (15,213)   (15,213)
Balance (in shares) at Jun. 30, 2024 76,900,123        
Balance at the end of the period at Jun. 30, 2024 $ 76 2,510,574 (16,498) (3,474,333) (980,181)
Balance (in shares) at Mar. 31, 2024 76,653,960        
Balance at the beginning of the period at Mar. 31, 2024 $ 76 2,486,722 (5,560) (3,375,154) (893,916)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 71,552        
Exercise of options   2,636     2,636
Restricted stock vesting and issuance, net (in shares) 67,466        
Issuance of common stock in connection with an employee stock purchase plan (in shares) 107,145        
Issuance of common stock in connection with an employee stock purchase plan   1,973     1,973
Share-based compensation expense   19,243     19,243
Net (loss) income       (99,179) (99,179)
Comprehensive income (loss)     (10,938)   (10,938)
Balance (in shares) at Jun. 30, 2024 76,900,123        
Balance at the end of the period at Jun. 30, 2024 $ 76 2,510,574 (16,498) (3,474,333) (980,181)
Balance (in shares) at Dec. 31, 2024 77,704,188        
Balance at the beginning of the period at Dec. 31, 2024 $ 77 2,574,611 (25,886) (3,646,873) (1,098,071)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 467,285        
Exercise of options   16,885     16,885
Restricted stock vesting and issuance, net (in shares) 1,134,189        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock in connection with an employee stock purchase plan (in shares) 72,483        
Issuance of common stock in connection with an employee stock purchase plan   2,827     2,827
Share-based compensation expense   36,603     36,603
Receivable from investor   254     254
Net (loss) income       801,713 801,713
Comprehensive income (loss)     33,242   33,242
Balance (in shares) at Jun. 30, 2025 79,378,145        
Balance at the end of the period at Jun. 30, 2025 $ 78 2,631,180 7,356 (2,845,160) (206,546)
Balance (in shares) at Mar. 31, 2025 79,225,276        
Balance at the beginning of the period at Mar. 31, 2025 $ 78 2,608,422 (13,949) (2,780,311) (185,760)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 36,196        
Exercise of options   1,134     1,134
Restricted stock vesting and issuance, net (in shares) 44,190        
Issuance of common stock in connection with an employee stock purchase plan (in shares) 72,483        
Issuance of common stock in connection with an employee stock purchase plan   2,827     2,827
Share-based compensation expense   18,543     18,543
Receivable from investor   254     254
Net (loss) income       (64,849) (64,849)
Comprehensive income (loss)     21,305   21,305
Balance (in shares) at Jun. 30, 2025 79,378,145        
Balance at the end of the period at Jun. 30, 2025 $ 78 $ 2,631,180 $ 7,356 $ (2,845,160) $ (206,546)